- Home
- BVFL vs ORMP Comparison
BVFL vs ORMP Comparison
Compare BVFL & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVFL | ORMP |
|---|---|---|
| Founded | 1873 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.6M | 165.3M |
| IPO Year | 2023 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BVFL | ORMP |
|---|---|---|
| Price | $21.35 | $4.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.1K | ★ 429.4K |
| Earning Date | 04-24-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 31.19 | ★ 412.50 |
| EPS | 0.13 | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $164.08 | ★ $5.10 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $14.60 | $1.98 |
| 52 Week High | $22.17 | $5.19 |
Technical Indicators
Market Signals| Indicator | BVFL | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 66.40 |
| Support Level | $18.07 | $3.21 |
| Resistance Level | N/A | $5.01 |
| Average True Range (ATR) | 0.84 | 0.28 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 74.32 | 74.39 |
Price Performance
Historical ComparisonAbout BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.